diatrizoate meglumine has been researched along with Hematologic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amitai, M; Apter, S; Guranda, L; Hertz, M; Nagler, A; Portnoy, O; Rimon, U; Shimoni, A; Yerushalmi, R | 1 |
1 other study(ies) available for diatrizoate meglumine and Hematologic Neoplasms
| Article | Year |
|---|---|
CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract.
Topics: Abdominal Pain; Acute Disease; Adult; Contrast Media; Diarrhea; Diatrizoate Meglumine; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Prognosis; Retrospective Studies; Stem Cell Transplantation; Tomography, Spiral Computed; Transplantation, Homologous | 2012 |